Dr. Barbara Kahn, MD

NPI: 1558300970
Total Payments
$197,865
2024 Payments
$25.34
Companies
5
Transactions
41

Payment Breakdown by Category

Consulting$194,183 (98.1%)
Travel$2,882 (1.5%)
Food & Beverage$799.69 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $194,183 25 98.1%
Travel and Lodging $2,882 6 1.5%
Food and Beverage $799.69 10 0.4%

Top Paying Companies

Company Total Records Latest Year
Janssen Research & Development, LLC $188,301 37 $0 (2023)
Ironwood Pharmaceuticals, Inc $5,425 1 $0 (2018)
Alnylam Pharmaceuticals Inc. $4,095 1 $0 (2021)
Ferring Pharmaceuticals Inc. $25.34 1 $0 (2024)
Astellas Pharma US Inc $18.32 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $25.34 1 Ferring Pharmaceuticals Inc. ($25.34)
2023 $16,817 4 Janssen Research & Development, LLC ($16,799)
2022 $26,091 3 Janssen Research & Development, LLC ($26,091)
2021 $23,783 3 Janssen Research & Development, LLC ($19,688)
2020 $14,873 2 Janssen Research & Development, LLC ($14,873)
2019 $23,519 11 Janssen Research & Development, LLC ($23,519)
2018 $48,248 9 Janssen Research & Development, LLC ($42,823)
2017 $44,509 8 Janssen Research & Development, LLC ($44,509)

All Payment Transactions

41 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
04/08/2024 Ferring Pharmaceuticals Inc. ADSTILADRIN (Biological) Food and Beverage In-kind items and services $25.34 General
Category: ONCOLOGY
10/20/2023 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $11,025.00 General
08/17/2023 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $4,648.50 General
06/15/2023 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $1,125.00 General
04/27/2023 Astellas Pharma US Inc Myrbetriq (Drug) Food and Beverage In-kind items and services $18.32 General
Category: Urology
10/26/2022 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $21,546.23 General
07/25/2022 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $3,825.00 General
05/13/2022 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $720.00 General
11/12/2021 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $16,087.50 General
08/26/2021 Alnylam Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $4,095.00 General
02/18/2021 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $3,600.00 General
10/28/2020 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $12,937.50 General
02/21/2020 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $1,935.00 General
12/12/2019 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $21,477.46 General
11/21/2019 Janssen Research & Development, LLC Travel and Lodging In-kind items and services $740.64 General
11/21/2019 Janssen Research & Development, LLC Travel and Lodging In-kind items and services $360.10 General
11/21/2019 Janssen Research & Development, LLC Travel and Lodging In-kind items and services $309.50 General
11/21/2019 Janssen Research & Development, LLC Food and Beverage In-kind items and services $143.89 General
11/21/2019 Janssen Research & Development, LLC Travel and Lodging In-kind items and services $136.17 General
11/21/2019 Janssen Research & Development, LLC Food and Beverage In-kind items and services $126.23 General
11/21/2019 Janssen Research & Development, LLC Food and Beverage In-kind items and services $113.03 General
11/21/2019 Janssen Research & Development, LLC Food and Beverage In-kind items and services $65.00 General
11/21/2019 Janssen Research & Development, LLC Food and Beverage In-kind items and services $27.12 General
11/21/2019 Janssen Research & Development, LLC Food and Beverage In-kind items and services $19.42 General
12/10/2018 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $12,870.54 General

About Dr. Barbara Kahn, MD

Dr. Barbara Kahn, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558300970.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Kahn, MD has received a total of $197,865 in payments from pharmaceutical and medical device companies, with $25.34 received in 2024. These payments were reported across 41 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($194,183).

Practice Information

  • Specialty Endocrinology, Diabetes & Metabolism
  • Other Specialties Diabetes & Metabolism
  • Location Boston, MA
  • Active Since 06/05/2006
  • Last Updated 04/29/2011
  • Taxonomy Code 207RE0101X
  • Entity Type Individual
  • NPI Number 1558300970

Products in Payments

  • INVOKANA (Drug) $168.00
  • ADSTILADRIN (Biological) $25.34
  • Myrbetriq (Drug) $18.32

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Endocrinology, Diabetes & Metabolism Doctors in Boston